Lbx Pharmacy Chain Joint Stock Company’s Net Profit Rose 16.6% in First Three Quarters of 2022
Listen to the full version

Lbx Pharmacy Chain Joint Stock Company (老百姓大药房连锁股份有限公司) (603883.SH) reported a net profit of 713.5 million yuan in the first three quarters of 2022, up 16.6% year-on-year.
Meanwhile, the company posted 13.8 billion yuan in revenue, up 22.1% year-on-year.
At the end of the reporting period, it had 20.3 billion yuan in total assets and 13.4 billion yuan in total liabilities, with a liability-to-asset ratio of 66.2%.
Unlock exclusive discounts with a Caixin group subscription — ideal for teams and organizations.
Subscribe to both Caixin Global and The Wall Street Journal — for the price of one.
- PODCAST
- MOST POPULAR